Paragon 28 Past Earnings Performance

Past criteria checks 0/6

Paragon 28's earnings have been declining at an average annual rate of -73.8%, while the Medical Equipment industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 21% per year.

Key information

-73.8%

Earnings growth rate

-69.9%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate21.0%
Return on equity-26.9%
Net Margin-22.1%
Next Earnings Update08 May 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Paragon 28 makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:7GQ Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23216-4818030
30 Sep 23207-6717529
30 Jun 23201-6817128
31 Mar 23192-6716526
31 Dec 22181-6715925
30 Sep 22173-3314923
30 Jun 22162-2913821
31 Mar 22156-2212718
31 Dec 21147-1411316
30 Sep 21140-510114
30 Jun 2113448912
31 Mar 2112147912
31 Dec 2011137311
31 Dec 1910637410

Quality Earnings: 7GQ is currently unprofitable.

Growing Profit Margin: 7GQ is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 7GQ is unprofitable, and losses have increased over the past 5 years at a rate of 73.8% per year.

Accelerating Growth: Unable to compare 7GQ's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 7GQ is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-9.8%).


Return on Equity

High ROE: 7GQ has a negative Return on Equity (-26.92%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.